Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.540
+0.120 (2.71%)
At close: Aug 18, 2026, 4:00 PM EDT
4.600
+0.060 (1.32%)
After-hours: Aug 18, 2026, 4:37 PM EDT
Minerva Neurosciences Employees
Minerva Neurosciences had 7 employees as of December 31, 2025. The number of employees decreased by 1 or -12.50% compared to the previous year.
Employees
7
Change (1Y)
-1
Growth (1Y)
-12.50%
Revenue / Employee
n/a
Profits / Employee
-$56,335,674
Market Cap
216.77M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7 | -1 | -12.50% |
| Dec 31, 2024 | 8 | -1 | -11.11% |
| Dec 31, 2023 | 9 | 0 | - |
| Dec 31, 2022 | 9 | 0 | - |
| Dec 31, 2021 | 9 | -2 | -18.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Tonix Pharmaceuticals Holding | 142 |
| Invivyd | 122 |
| Alector | 103 |
| Immunic | 100 |
| Compugen | 75 |
| PepGen | 59 |
| NovaBridge Biosciences | 30 |
NERV News
- 2 days ago - Minerva upgraded to Buy from Hold at Jefferies - TheFly
- 11 days ago - Minerva Neurosciences Provides Second Quarter 2026 Financial Results and Business Updates - GlobeNewsWire
- 11 days ago - Minerva Neurosciences Earnings release: Q2 2026 - Filings
- 11 days ago - Minerva Neurosciences Quarterly report: Q2 2026 - Filings
- 2 months ago - Minerva Neurosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Minerva Neurosciences Transcript: AGM 2026 - Transcripts
- 2 months ago - Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs - GlobeNewsWire
- 3 months ago - Minerva Neurosciences Slides: Corporate presentation - Filings